A Study to Evaluate Intramuscular ASP7374
NCT01961960 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2017-09-29
Summary
The purpose of this study is to evaluate safety and immunogenicity of intramuscular ASP7374 in adults ≥61 years of age.
Conditions
- Influenza
- Vaccine
Interventions
- BIOLOGICAL
-
ASP7374
intramuscular
Sponsors & Collaborators
-
UMN Pharma Inc.
lead INDUSTRY
Principal Investigators
-
Medical Director · Astellas Pharma Inc
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 61 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2013-11-30
- Completion
- 2013-11-30
Countries
- Japan
More Related Trials
-
Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects
NCT01357265 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults
NCT05823974 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine
NCT00505453 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and Older
NCT06507553 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults
NCT00545701 ·Status: COMPLETED ·Phase: PHASE2
-
Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above
NCT07327398 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine
NCT01201902 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and Older
NCT07121192 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects
NCT00354016 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Test the Response to Different Vaccination Regimens With an H5N1 Vaccine With AS03 in Adults Aged 18-64
NCT00695669 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
NCT01746082 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above
NCT01640314 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older
NCT05650554 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008
NCT00511914 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity Study of the Influenza Vaccine in Adults
NCT00258934 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age
NCT01209780 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects
NCT00845429 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1)
NCT00989612 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.
NCT00316628 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
NCT01579916 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above
NCT04732871 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older
NCT05426174 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant
NCT02957656 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older
NCT05553301 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above
NCT01880697 ·Status: COMPLETED ·Phase: PHASE3